Tuesday, February 12, 2008
The National Immunization Software system recommends erythromycin as the preferred drug, although newer macrolides including azithromycin and clarithromycin appear to be similar. Communication should be given only if the symptoms are less than 4 weeks in time.
The whole-cell vaccines have worked very well but are associated with frequent anesthetic and systemic reactions. A large, randomized clinical visitation of the new acellular pertussis vaccine has now been conducted in nearly 3000 healthy subjects aged 15-65 age. The prelim data showed a 92% efficacy rate. The military science considered to have the greatest potential drop powerfulness (including cost-effectiveness) is pertussis inoculation of adolescents using acellular pertussis vaccine boosters.